Hide Board Information

Show Board Information

Aralez Pharmaceuticals Inc. ARLZQ

Board Mod: Add me as mod

Asst Mods:

Last Post: 07/23/2018 4:17:29 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 18

ARLZ


Aralez Pharmaceuticals Inc.

Aralez Pharmaceuticals Inc. (OTCMRKTS: ARLZQ) Stock Message Board

1. ARLZQ Company Profile

    

2. ARLZQ Time & Sales

    

3. ARLZQ Recent News

    

4. ARLZQ Filings

    

5. ARLZQ Financials

    

6. ARLZQ Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

6	36% 5.4M C.4287 even more vol today!!! Who has	znewcar1	07/23/2018 4:17:29 PM
5	Nice upturn there z.	PoemStone	07/21/2018 11:33:37 AM
4	25% 3.6M C.315 oversold? dead cat bounce?	znewcar1	07/20/2018 4:07:34 PM
3	8% 4.5M C.462 H.5 WL has potential to back	znewcar1	06/13/2018 4:23:03 PM
2	14% 7.7M C.5027 h.5279 rock steady	znewcar1	05/11/2018 4:54:20 PM
1	md 6% dip and ripping to hod$.49 it get vol then	znewcar1	05/11/2018 12:20:56 PM

Recent Articles

• Insights into the Latest Riksbank Certificate Auction Results
• Robex Resources Advances Kiniero Gold Project Toward Production
• Temenos Achieves Prestigious Certification in Multiple Countries
• Transforming B2B Sales Intelligence with New Insights
• Rakovina Therapeutics Advances Cancer Research with AI Insights
• Jacobs Takes the Lead in Innovative Tunnel Infrastructure
• YouTube TV's Tense Negotiations Threaten Fox Channels Access
• CNOOC Limited Expands Exploration Footprint with New PSCs
• Trump Issues Stern Warning on China Tariffs, Talks Resume
• Hisense Shines with EISA Awards for Sound and Image Innovation
• Gentoo Media Reports Q2 2025 Performance and Future Outlook
• Exploring New Horizons: CNOOC's Growth in Indonesia's Energy Sector
• Gentoo Media's Q2 2025 Highlights and Strategic Updates
• HashKey Japan: Embracing the Future of Digital Assets
• ZKONG Elevates ESL Market with Custom Solutions and Security
• Strategic Investment Collaboration between Brevan Howard and Lunate
• Experience Cutting-Edge Golf Technology with NEO-E Launch
• C&K Paving Welcomes Tom O'Toole as New Regional Director
• Brevan Howard and Lunate Launch Strategic Investment Platform
• Innovative Base Editing Treatment Marks Breakthrough for Sickle Cell
• Jacobs Partners on Historic Marselis Tunnel Initiative in Denmark
• Arasan Chip Systems' MIPI DSI-2 Rx Controller Hits a Milestone
• Comprehensive Guide to Riksbank Certificates Auction Details
• Boeing and Korean Air Announce Historic $36 Billion Purchase
• Top Stocks to Keep an Eye on as Markets Shift
• Forecasting Federal Reserve Rate Cuts: Insights from Morgan Stanley
• Market Update: Dow Drops Over 300 Points Amid Shifting Trends
• Updated Insight on Box, Inc.'s Q2 Earnings Forecasts
• Papa John's Exciting Comeback in India with Major Expansion Plans
• New Insights on China: The Role of Diplomacy and Global Stability
• Market Faces Uncertainty Amid Ninja Earnings and Political Change
• EHang's Remarkable Q2 Growth and Future Endeavors
• EHang Holdings Reports Remarkable Revenue Surge This Quarter
• BC.GAME to Make Major Impact as Kwara United FC's Sponsor
• ProLogium Unveils Innovative Solid-State Battery Future Plans
• Third Point LLC's Strategic Shift: Investing in Tech and AI
• Sungrow's PowerTitan 3.0: Revolutionizing Energy Storage Solutions
• Market Insights: S&P 500 Faces Critical Support Levels Ahead
• Nvidia's Earnings Are Just Around the Corner: What to Expect
• Apax Global Alpha Limited: Recent Trading Activity Overview
• Dowlais Group plc: A Deep Dive into Recent Trading Activities
• FansRevenue's Strategic Acquisition of DivaTraffic Explained
• Key Financial Reporting Dates and Company Contacts Explained
• Africa's Wealth Surge: Millionaire Growth and Economic Trends
• Employee Distraction Emerges as Major Cybersecurity Risk
• Appian's Recognition as a Leader in Business Automation 2025
• Exploring Regenerative Farming with AgriTec and Andy Garcia
• Exploring the Vital Role of Open Source in AI Sovereignty
• Shifting Investment Focus: Exploring Diversification Beyond Tech
• PannTheraPi Moves Forward with Exciting Clinical Developments